Protalix BioTherapeutics, Inc. Share Price TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 13/05 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 19Cr 0 17Cr 16Cr 14Cr 27Cr 1.84TCr 27Cr 185.21Cr 72Cr 904.07Cr 72Cr 70Cr 3.13TCr | P/E 2026 * |
12.2x | P/E 2027 * | 47.4x |
|---|---|---|---|---|---|
| Enterprise Value | 19Cr 0 17Cr 16Cr 14Cr 27Cr 1.84TCr 27Cr 185.21Cr 72Cr 904.07Cr 72Cr 70Cr 3.13TCr | EV / Sales 2026 * |
2.44x | EV / Sales 2027 * | 2.83x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 19Cr | |
| +0.51% | +4.74% | +48.65% | +164.02% | 1,06700Cr | |
| +1.47% | +7.03% | +60.21% | +53.32% | 63TCr | |
| +0.58% | +3.17% | +38.66% | +75.61% | 46TCr | |
| +1.87% | +9.10% | +38.87% | +32.83% | 35TCr | |
| +1.71% | +4.94% | +38.40% | +42.35% | 30TCr | |
| +2.10% | +4.80% | +20.24% | +21.25% | 26TCr | |
| +2.00% | -1.01% | -28.03% | -38.99% | 22TCr | |
| +1.41% | +4.52% | +26.34% | +61.25% | 20TCr | |
| +2.56% | -1.37% | +16.24% | +71.73% | 16TCr | |
| Average | +1.39% | +1.33% | +28.84% | +53.71% | 40.48TCr | |
| Weighted average by Cap. | +1.24% | +1.95% | +38.39% | +79.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.83Cr 0 6.88Cr 6.4Cr 5.87Cr 11Cr 754.02Cr 11Cr 76Cr 30Cr 370.7Cr 29Cr 29Cr 1.28TCr | 6.76Cr 0 5.93Cr 5.52Cr 5.06Cr 9.51Cr 650.65Cr 9.66Cr 66Cr 26Cr 319.88Cr 25Cr 25Cr 1.11TCr |
| Net income | 1.57Cr 0 1.38Cr 1.28Cr 1.18Cr 2.21Cr 151.41Cr 2.25Cr 15Cr 5.96Cr 74Cr 5.9Cr 5.78Cr 257.37Cr | 40.74L 0 35.78L 33.27L 30.53L 57.37L 39Cr 58.25L 3.95Cr 1.54Cr 19Cr 1.53Cr 1.5Cr 67Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
